Poulias Iraklis Urologist
Director of 2nd Urology ClinicEducation & Academic Qualifications
- 1978: Degree in Medicine, Faculty of Medicine, University of Athens
- 1984: Urology specialty license, Prefecture of Attica
- 2000: Postdoctoral fellow, Yale University
- 2006: Diplôme d’Université Strasbourg
Doctoral Thesis
1990: “BCG immunotherapy for superficial urinary bladder tumors and investigation of clinical and lab response using monoclonal antibodies”, University of Athens
Posts in Scientific Societies and Organizations
Special Secretary, Hellenic Urological Society, 1991-1993
Member of the Editorial Committee, Hellenic Urological Society journal, 2009-2014
Member of the Scholarship Committee, Hellenic Urological Society journal, 2011-2014
Chairman of the Moderating Committee, Genitourinary Oncology Department, Hellenic Urological Society, 2013-2015
Member of the Advisory Committee, South Eastern European Meeting (SEEM), 2009-2012
Member of the specialty review committee, 2012-2015
Vice-Chairman, Hellenic Urological Society
Chairman of the Education Committee, Hellenic Urological Society
Chairman of the Hellenic Urological Society, since 01/01/2017
Membership in International Scientific Societies
European Association of Urology (EUA)
International Endourological Society
Société Internationale d’Urologie (SIU)
Work Experience
1985-1987: Registrar Urologist, North Manchester General Hospital
1987-1995: Registrar B, Urology Clinic, Korgialeneio-Benakeio Red Cross Hospital
1995-2003: Registrar A, Urology Clinic, Korgialeneio-Benakeio Red Cross Hospital
2003-2010: Director, Urology Clinic, Korgialeneio-Benakeio Red Cross Hospital
- 2008-2015: Coordinator, Urology Clinic, Korgialeneio-Benakeio Red Cross Hospital
Scientific Activities
Authorship of monograph: “Superficial Bladder Cancer: Modern Diagnostic and Therapeutic Approach”, Athens, 2001
Participation in books: “Modern Views in Treating Multiple Trauma Patients”, Stomias, Athens, 2000
“Laparoscopic & Minimally Invasive Surgery”, Urology Procedures, Athens, 2002
Participation in 12 clinical trials and international research protocols
52 articles in Greek and foreign journals
Awards
Best poster prize at a Greek Urology Conference
Best poster prize at the SEEM conference, Thessaloniki, 2009
Clinical & Research Interest
Genitourinary cancer
Benign prostatic hyperplasia
Urinary tract stones
Urogynecology
Male fertility
Recent Publications
Differential immunohistochemical expression of CD44s, E-cadherin and β-catenin among hyperplastic and neoplastic lesions of the prostate gland. Lazari P, Poulias H, Gakiopoulou H, Thomopoulou GH, Barbatis C, Lazaris AC.Urol Int. 2013;90(1):109-16. doi: 10.1159/000345057. Epub 2012 Dec 5.PMID:23220849
Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors.Ferakis N, Bouropoulos C, Granitsas T, Mylona S, Poulias I.J Endourol. 2010 Dec;24(12):1909-13. doi: 10.1089/end.2009.0639. Epub 2010 Oct 14.PMID:20946062
Is there any potential link among caspase-8, p-p38 MAPK and bcl-2 in clear cell renal cell carcinomas? A comparative immunohistochemical analysis with clinical connotations.Samaras V, Tsopanomichalou M, Stamatelli A, Arnaoutoglou C, Samaras E, Arnaoutoglou M, Poulias H, Barbatis C.Diagn Pathol. 2009 Feb 17;4:7. doi: 10.1186/1746-1596-4-7.PMID:19222834
Transrectal ultrasonography and ultrasound-guided biopsies of the prostate gland: how, when, and where.Papatheodorou A, Ellinas P, Tandeles S, Takis F, Poulias H, Nikolaou I, Batakis N.Curr Probl Diagn Radiol. 2005 Mar-Apr;34(2):76-83. No abstract available.PMID:15753881
Two cycles of etoposide/cisplatin cured all patients with stage I testicular seminoma: risk-adapted protocol of the Hellenic Cooperative Oncology Group.Bamias A, Aravantinos G, Deliveliotis C, Thanos A, Klouvas G, Antoniou N, Poulias I, Makatsoris T, Samantas E, Dimopoulos MA.Urology. 2007 Dec;70(6):1179-83.PMID:18158042